A case of anaphylactic shock induced by pirarubicin hydrochloride

A 75-year-old man was admitted to our hospital for treatment of superficial bladder tumor. Transurethral resection (TUR) was performed and histopathological examination revealed a transitional cell carcinoma (G2). Despite one course of post-TUR bladder instillation therapy using pirarubicin hydrochl...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 50(2004), 4 vom: 06. Apr., Seite 257-9
1. Verfasser: Mitsuhashi, Makoto (VerfasserIn)
Weitere Verfasser: Iwata, Hiroyuki, Kiyota, Atsuhiko, Kamizuru, Masato, Nakatani, Tatsuya
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports English Abstract Journal Article Vinblastine 5V9KLZ54CY Doxorubicin 80168379AG pirarubicin D58G680W0G Cisplatin mehr... Q20Q21Q62J Methotrexate YL5FZ2Y5U1
Beschreibung
Zusammenfassung:A 75-year-old man was admitted to our hospital for treatment of superficial bladder tumor. Transurethral resection (TUR) was performed and histopathological examination revealed a transitional cell carcinoma (G2). Despite one course of post-TUR bladder instillation therapy using pirarubicin hydrochloride, carcinoma in situ (CIS) was found 4 months later. CIS disappeared after another course of bladder instillation therapy using BCG; but, it recurred a month later. BCG bladder instillation therapy was performed again, and no malignant cells were detected in the urinary tract thereafter. Four months later, lung metastasis was diagnosed and an MVAC regimen (cisplatin, methotrexate, vinblastin adriamycin) was administered. However, anaphylactic shock was induced by intravenous injection of pirarubicin hydrochloride, so this therapy was stopped in the middle of the second course. Even though the lung metastasis disappeared once after the same MVAC treatment, it recurred the following year. At that time, 3 courses of a cisplatin-methotrexate-vinblastin regimen were administered, and a complete response was achieved
Beschreibung:Date Completed 22.06.2004
Date Revised 20.11.2014
published: Print
Citation Status MEDLINE
ISSN:0018-1994